Maxim Group Forecasts Health In Tech Q3 Earnings

Health In Tech, Inc. (NASDAQ:HIT) – Stock analysts at Maxim Group issued their Q3 2026 EPS estimates for Health In Tech in a research note issued to investors on Friday, August 14th. Maxim Group analyst A. Klee anticipates that the company will post earnings of ($0.04) per share for the quarter. Maxim Group has a “Buy” rating and a $3.00 price target on the stock. Maxim Group also issued estimates for Health In Tech’s Q4 2026 earnings at ($0.03) EPS, FY2026 earnings at ($0.10) EPS, Q1 2027 earnings at $0.01 EPS, Q2 2027 earnings at ($0.01) EPS, Q3 2027 earnings at $0.00 EPS, Q4 2027 earnings at ($0.02) EPS and FY2027 earnings at ($0.02) EPS.

A number of other analysts have also recently issued reports on HIT. Wall Street Zen cut Health In Tech from a “hold” rating to a “sell” rating in a research report on Saturday, April 25th. Craig Hallum started coverage on shares of Health In Tech in a report on Monday, April 20th. They issued a “buy” rating and a $4.00 price target on the stock. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Health In Tech in a research note on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Health In Tech currently has a consensus rating of “Moderate Buy” and an average target price of $3.50.

Health In Tech Stock Up 0.5%

HIT stock opened at $1.01 on Tuesday. Health In Tech has a twelve month low of $0.85 and a twelve month high of $4.02. The company has a market cap of $66.19 million, a PE ratio of -14.43 and a beta of 2.82. The business’s 50-day simple moving average is $1.06 and its 200 day simple moving average is $1.25.

Health In Tech (NASDAQ:HIT) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01). The business had revenue of $8.06 million for the quarter.

Institutional Investors Weigh In On Health In Tech

Institutional investors and hedge funds have recently made changes to their positions in the company. XTX Topco Ltd acquired a new stake in shares of Health In Tech during the 4th quarter worth about $203,000. State Street Corp grew its stake in Health In Tech by 195.3% during the fourth quarter. State Street Corp now owns 62,900 shares of the company’s stock worth $100,000 after buying an additional 41,600 shares during the last quarter. Jane Street Group LLC increased its holdings in shares of Health In Tech by 307.9% during the fourth quarter. Jane Street Group LLC now owns 50,648 shares of the company’s stock worth $81,000 after buying an additional 38,230 shares in the last quarter. Renaissance Technologies LLC acquired a new position in shares of Health In Tech in the 4th quarter worth approximately $214,000. Finally, Geode Capital Management LLC grew its holdings in shares of Health In Tech by 46.6% during the fourth quarter. Geode Capital Management LLC now owns 170,502 shares of the company’s stock worth $271,000 after purchasing an additional 54,217 shares during the last quarter.

Health In Tech Company Profile

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.